Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108772
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108772
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108772
Figure 2 Intervention in the management of non-alcoholic fatty liver disease.
The figure highlights various therapeutic interventions aimed at restoring gut and liver health, including dietary modifications incorporating antioxidants and hepatoprotective nutrients, microbiome-targeted approaches using probiotics and postbiotics like short-chain fatty acids, and the use of essential metal, Selenium. These strategies collectively help in enhancing gut integrity, reducing inflammation, and improving metabolic outcomes. SCFA: Short-chain fatty acid; IL-6: Interleukin-6; IL-1β: Interleukin-1β.
- Citation: Sharma T, Kaushal N, Garla R. Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression. World J Hepatol 2025; 17(8): 108772
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108772.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108772